GURUFOCUS.COM » STOCK LIST » USA » NAS » Syneos Health Inc (NAS:SYNH) » Definitions » 14-Day RSI
Switch to:

Syneos Health 14-Day RSI

: 44.10 (As of Today)
View and export this data going back to 2014. Start your Free Trial

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2022-08-13), Syneos Health's 14-Day RSI is 44.10.

The industry rank for Syneos Health's 14-Day RSI or its related term are showing as below:

SYNH's 14-Day RSI is ranked better than
72.58% of 248 companies
in the Medical Diagnostics & Research industry
Industry Median: 52.49 vs SYNH: 44.10

Competitive Comparison

For the Diagnostics & Research subindustry, Syneos Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Syneos Health 14-Day RSI Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Syneos Health's 14-Day RSI falls into.



Syneos Health  (NAS:SYNH) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syneos Health  (NAS:SYNH) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Syneos Health 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Syneos Health's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health Business Description

Syneos Health logo
Traded in Other Exchanges
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Executives
Zulueta Alfonso G director LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Bodem Barbara W. director C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277
Brooks Michael Lee officer: See remarks C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Wilkes David S. director ONE BAXTER PARKWAY DEERFIELD IL 60015
Connaughton Bernadette director C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139
Klitgaard William E director 210 CARNEGIE CENTER PRINCETON NJ 08540
Meyers Kenneth F director 275 NORTH FIELD DRIVE LAKE FOREST IL 60045
Monaghan Matthew E. director ONE INVACARE WAY ELYRIA OH 44035
Harty Linda S director MEDTRONIC PLC 710 MEDTRONIC PARKWAY NE, LC-150 MINNEAPOLIS MN 55432
Kralowetz Donna Hildebrand officer: SVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Colvin Paul officer: Pres., Clinical Solutions C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Parks Robert officer: EVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Olefson Jonathan officer: General Counsel & Corp Secty C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Meggs Jason M. officer: Chief Financial Officer C/O SYNEOS HEALTH, INC. 1030 SYNC STREET MORRISVILLE NC 27560
Gpe Vii Gp S.a.r.l. 10 percent owner CO ADVENT INTERNATIONAL 800 BOYLSTON STREET BOSTON MA 02199

Syneos Health Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)